Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
November 2013 Volume 30 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November 2013 Volume 30 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients

  • Authors:
    • Marijke De Couck
    • David van Brummelen
    • Denis Schallier
    • Jacques De Grève
    • Yori Gidron
  • View Affiliations / Copyright

    Affiliations: Faculty of Medicine and Pharmacy, Free University of Brussels (VUB), Brussels, Belgium, Department of Medical Oncology, Oncological Center UZ Brussels, Brussels, Belgium
  • Pages: 2435-2441
    |
    Published online on: September 9, 2013
       https://doi.org/10.3892/or.2013.2725
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Recent studies suggest that vagal nerve activity, indexed by heart rate variability (HRV), could have a prognostic role in cancer. However, most studies did not control adequately for confounders and included cardiac patients. Furthermore, the validity of this prognostic role needs to be tested in different types of cancer. The present study tested the prognostic role of HRV in prostate cancer (PC) and non-small cell lung cancer (NSCLC) patients, using a historical prospective design. HRV was derived from brief 10 sec ECGs obtained at approximately the time of diagnosis in 113 PC patients and 133 NSCLC patients. Outcomes included prostate-specific antigen (PSA) at 6 and 24 months in PC, and overall survival (OS) (for the full sample) and survival time (for the deceased patients) in NSCLC. Furthermore, the possible mediating role of C-reactive protein (CRP) was tested (in NSCLC), as well as whether age and stage moderated the relationship between HRV and prognosis in both types of cancer. In the PC patients, HRV significantly inversely predicted PSA levels at 6 and 24 months, independent of confounders. Furthermore, this was particularly significant in metastatic PC patients, indicating moderation by stage. In NSCLC patients, HRV did not predict OS and survival time, but it did positively predict survival time in patients under the age of 65, independent of confounders. Additionally, CRP was not found to mediate the relationship between HRV and OS or survival time in NSCLC. The present results partly support previous studies and extend them to two additional common types of cancer, using a more rigorous control over confounders. Together with recent experimental findings, these results propose a modulatory role of vagal nerve activity in cancer. Therefore, routine measurement of HRV in estimating prognosis in cancer may be considered.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar

2 

Eastham JA: Prostate-specific antigen doubling time as a prognostic marker in prostate cancer. Nat Clin Pract Urol. 2:482–491. 2005. View Article : Google Scholar : PubMed/NCBI

3 

de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, Cheng T, Patterson H, Hainsworth JD, Ryan CJ, Sternberg CN, Ellard SL, Fléchon A, Saleh M, Scholz M, Efstathiou E, Zivi A, Bianchini D, Loriot Y, Chieffo N, Kheoh T, Haqq CM and Scher HI; COU-AA-301 Investigators. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. 364:1995–2005. 2011.

4 

Kelsey CR, Marks LB, Hollis D, Hubbs JL, Ready NE, D’Amico TA and Boyd JA: Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients. Cancer. 115:5218–5227. 2009.PubMed/NCBI

5 

Rosell R, Molina MA, Costa C, Simonetti S, Gimenez-Capitan A, Bertran-Alamillo J, Mayo C, Moran T, Mendez P, Cardenal F, Isla D, Provencio M, Cobo M, Insa A, Garcia-Campelo R, Reguart N, Majem M, Viteri S, Carcereny E, Porta R, Massuti B, Queralt C, de Aguirre I, Sanchez JM, Sanchez-Ronco M, Mate JL, Ariza A, Benlloch S, Sanchez JJ, Bivona TG, Sawyers CL and Taron M: Pretreatment EGFR T790M mutation and BRCA1 mRNA expression in erlotinib-treated advanced non-small-cell lung cancer patients with EGFR mutations. Clin Cancer Res. 17:1160–1168. 2011. View Article : Google Scholar

6 

Gandhi L and Janne PA: Crizotinib for ALK-rearranged non-small cell lung cancer: a new targeted therapy for a new target. Clin Cancer Res. 18:3737–3742. 2012. View Article : Google Scholar : PubMed/NCBI

7 

Brundage MD, Davies D and Mackillop WJ: Prognostic factors in non-small cell lung cancer: a decade of progress. Chest. 122:1037–1057. 2002. View Article : Google Scholar : PubMed/NCBI

8 

Marijon H, Bouyon A, Vignot S and Besse B: Prognostic and predictive factors in lung cancer. Bull Cancer. 96:391–404. 2009.PubMed/NCBI

9 

Lee JH, Song EM, Sim YS, Ryu YJ and Chang JH: Forced expiratory volume in one second as a prognostic factor in advanced non-small cell lung cancer. J Thorac Oncol. 6:305–309. 2011.PubMed/NCBI

10 

Valko M, Izakovic M, Mazur M, Rhodes CJ and Telser J: Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem. 266:37–56. 2004. View Article : Google Scholar : PubMed/NCBI

11 

Faux SP, Tai T, Thorne D, Xu Y, Breheny D and Gaca M: The role of oxidative stress in the biological responses of lung epithelial cells to cigarette smoke. Biomarkers. 14:90–96. 2009. View Article : Google Scholar : PubMed/NCBI

12 

Maki A, Kono H, Gupta M, Asakawa M, Suzuki T, Matsuda M, Fujii H and Rusyn I: Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma. Ann Surg Oncol. 14:1182–1190. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E and Ben-Neriah Y: NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature. 431:461–466. 2004. View Article : Google Scholar : PubMed/NCBI

14 

Voronov E, Shouval DS, Krelin Y, et al: IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA. 100:2645–2650. 2003. View Article : Google Scholar : PubMed/NCBI

15 

Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008. View Article : Google Scholar

16 

Entschladen F, Drell TL IV, Lang K, Joseph J and Zaenker KS: Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. Lancet Oncol. 5:254–258. 2004. View Article : Google Scholar : PubMed/NCBI

17 

Tracey KJ: Reflex control of immunity. Nat Rev Immunol. 9:418–428. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Ek M, Kurosawa M, Lundeberg T and Ericsson A: Activation of vagal afferents after intravenous injection of interleukin-1beta: role of endogenous prostaglandins. J Neurosci. 18:9471–9479. 1998.PubMed/NCBI

19 

Pavithran P, Nandeesha H, Sathiyapriya V, Bobby Z and Madanmohan T: Short-term heart variability and oxidative stress in newly diagnosed essential hypertension. Clin Exp Hypertens. 30:486–496. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Vlcek M, Radikova Z, Penesova A, et al: Heart rate variability and catecholamines during hypoglycemia and orthostasis. Auton Neurosci. 143:53–57. 2008. View Article : Google Scholar : PubMed/NCBI

21 

De Couck M, Mravec B and Gidron Y: You may need the vagus nerve to understand pathophysiology and to treat diseases. Clin Sci. 122:323–328. 2012.PubMed/NCBI

22 

Gidron Y, Perry H and Glennie M: Does the vagus nerve inform the brain about preclinical tumours and modulate them? Lancet Oncol. 6:245–248. 2005. View Article : Google Scholar : PubMed/NCBI

23 

Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 93:1043–1065. 1996. View Article : Google Scholar : PubMed/NCBI

24 

Kuo TB, Lai CJ, Huang YT and Yang CC: Regression analysis between heart rate variability and baroreflex-related vagus nerve activity in rats. J Cardiovasc Electrophysiol. 16:864–869. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Hoffmann J, Grimm W, Menz V, Wied M, Sprenger A, Arnold R and Maisch B: Prognostic value of heart rate variability analysis in patients with carcinoid syndrome. Digestion. 63:35–42. 2001. View Article : Google Scholar : PubMed/NCBI

26 

Fadul N, Strasser F, Palmer LJ, Yusuf SW, Guo Y, Li Z, Allo J and Bruera E: The association between autonomic dysfunction and survival in male patients with advanced cancer: a preliminary report. J Pain Symptom Manage. 39:283–290. 2010. View Article : Google Scholar : PubMed/NCBI

27 

Chiang JK, Koo M, Kuo TB and Fu CH: Association between cardiovascular autonomic functions and time to death in patients with terminal hepatocellular carcinoma. J Pain Symptom Manage. 39:673–679. 2010. View Article : Google Scholar

28 

Kim do H, Kim JA, Choi YS, Kim SH, Lee JY and Kim YE: Heart rate variability and length of survival in hospice cancer patients. J Korean Med Sci. 25:1140–1145. 2010.PubMed/NCBI

29 

Mouton C, Ronson A, Razavi D, Delhaye F, Kupper N, Paesmans M, Moreau M, Nogaret JM, Hendlisz A and Gidron Y: The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer. Auton Neurosci. 166:96–99. 2012. View Article : Google Scholar : PubMed/NCBI

30 

Crimmins EM, Johnston M, Hayward M and Seeman T: Age differences in allostatic load: an index of physiological dysregulation. Exp Gerontol. 38:731–734. 2003. View Article : Google Scholar : PubMed/NCBI

31 

Pfleger CC, Flachs EM and Koch-Henriksen N: Social consequences of multiple sclerosis: clinical and demographic predictors - a historical prospective cohort study. Eur J Neurol. 17:1346–1351. 2010.PubMed/NCBI

32 

Lerner-Geva L, Keinan-Boker L, Blumstein T, Boyko V, Olmar L, Mashiach S, Rabinovici J, Potashnik G, Lunenfeld E, Schenker JG, Shushan A, Fishman A, Cohen I, Vagman I and Lunenfeld B: Infertility, ovulation induction treatments and the incidence of breast cancer - a historical prospective cohort of Israeli women. Breast Cancer Res Treat. 100:201–212. 2006. View Article : Google Scholar : PubMed/NCBI

33 

Thong T, Li K, McNames J, Aboy M and Goldstein B: Accuracy of ultra-short heart rate variability measures. Engineering in Medicine and Biology Society. Proc 25th Annual Int Conference of the IEEE. 3:2424–2427. 2003.

34 

Nussinovitch U, Elishkevitz KP, Katz K, Nussinovitch M, Segev S, Volovitz B and Nussinovitch N: Reliability of ultra-short ECG indices for heart rate variability. Ann Noninvasive Electrocardiol. 16:117–122. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Hodgart E and Macfarlane PW: 10 second heart rate variability. Comp Cardiol. 31:217–220. 2004.

36 

Schipke JD, Pelzer M and Arnold G: Effect of respiration rate on short-term heart rate variability. J Clin Basic Cardiol. 2:92–94. 1999.

37 

Poyhonen M, Syvaoja S, Hartikainen J, Ruokonen E and Takala J: The effect of carbon dioxide, respiratory rate and tidal volume on human heart rate variability. Acta Anaesthesiol Scand. 48:93–101. 2004.PubMed/NCBI

38 

Strauss-Blasche G, Moser M, Voica M, McLeod DR, Klammer N and Marktl W: Relative timing of inspiration and expiration affects respiratory sinus arrhythmia. Clin Exp Pharmacol Physiol. 27:601–606. 2000. View Article : Google Scholar : PubMed/NCBI

39 

Brown JK, Cooley ME, Chernecky C and Sarna L: A symptom cluster and sentinel symptom experienced by women with lung cancer. Oncol Nurs Forum. 38:E425–E435. 2011. View Article : Google Scholar : PubMed/NCBI

40 

Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS and Gulsvik A: Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med. 173:1316–1325. 2006. View Article : Google Scholar : PubMed/NCBI

41 

Katona PG and Jih F: Respiratory sinus arrhythmia: noninvasive measure of parasympathetic cardiac control. J Appl Physiol. 39:801–805. 1975.PubMed/NCBI

42 

Cassart M, Pettiaux N, Gavenois PA, Pavia M and Estenne M: Effect of chronic hyperinflation on diaphragm length and surface area. Am J Respir Crit Care Med. 156:504–508. 1997. View Article : Google Scholar : PubMed/NCBI

43 

Alifano M, Falcoz PE, Seegers V, Roche N, Schussler O, Younes M, Antonacci F, Forgez P, Dechartres A, Massard G, Damotte D and Régnard JF: Preresection serum C-reactive protein measurement and survival among patients with resectable non-small cell lung cancer. J Thorac Cardiovasc Surg. 142:1161–1167. 2011. View Article : Google Scholar : PubMed/NCBI

44 

Hamilton RM, McKechnie PS and Macfarlane PW: Can cardiac vagal tone be estimated from the 10-second ECG? Int J Cardiol. 95:109–115. 2004. View Article : Google Scholar : PubMed/NCBI

45 

Dekker JM, Schouten EG, Klootwijk P, Pool J, Swenne CA and Kromhout D: Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol. 145:899–908. 1997. View Article : Google Scholar : PubMed/NCBI

46 

O’Donnell K, Brydon L, Wright CE and Steptoe A: Self-esteem levels and cardiovascular and inflammatory responses to acute stress. Brain Behav Immun. 22:1241–1247. 2008.PubMed/NCBI

47 

Erin N, Akdas Barkan G, Harms JF and Clawson GA: Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level. Regul Pept. 151:35–42. 2008. View Article : Google Scholar : PubMed/NCBI

48 

Erin N, Boyer PJ, Bonneau RH, Clawson GA and Welch DR: Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart. Anticancer Res. 24:1003–1009. 2004.PubMed/NCBI

49 

Erin N, Duymuş O, Oztürk S and Demir N: Activation of vagus nerve by semapimod alters substance P levels and decreases breast cancer metastasis. Regul Pept. 179:101–108. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
De Couck M, van Brummelen D, Schallier D, De Grève J and Gidron Y: The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients . Oncol Rep 30: 2435-2441, 2013.
APA
De Couck, M., van Brummelen, D., Schallier, D., De Grève, J., & Gidron, Y. (2013). The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients . Oncology Reports, 30, 2435-2441. https://doi.org/10.3892/or.2013.2725
MLA
De Couck, M., van Brummelen, D., Schallier, D., De Grève, J., Gidron, Y."The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients ". Oncology Reports 30.5 (2013): 2435-2441.
Chicago
De Couck, M., van Brummelen, D., Schallier, D., De Grève, J., Gidron, Y."The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients ". Oncology Reports 30, no. 5 (2013): 2435-2441. https://doi.org/10.3892/or.2013.2725
Copy and paste a formatted citation
x
Spandidos Publications style
De Couck M, van Brummelen D, Schallier D, De Grève J and Gidron Y: The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients . Oncol Rep 30: 2435-2441, 2013.
APA
De Couck, M., van Brummelen, D., Schallier, D., De Grève, J., & Gidron, Y. (2013). The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients . Oncology Reports, 30, 2435-2441. https://doi.org/10.3892/or.2013.2725
MLA
De Couck, M., van Brummelen, D., Schallier, D., De Grève, J., Gidron, Y."The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients ". Oncology Reports 30.5 (2013): 2435-2441.
Chicago
De Couck, M., van Brummelen, D., Schallier, D., De Grève, J., Gidron, Y."The relationship between vagal nerve activity and clinical outcomes in prostate and non-small cell lung cancer patients ". Oncology Reports 30, no. 5 (2013): 2435-2441. https://doi.org/10.3892/or.2013.2725
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team